Erratum: SAPIEN 3 versus Myval bij TAVI (COMPARE-TAVI 1)

Terkelsen CJ, Freeman P, Dahl JS, et al. SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial. Lancet 2025; 405: 1362–72—In this Article, the authors identified an error in the dataset that resulted in four patients being misclassified as having moderate or severe transcatheter heart valve (THV) deterioration. This misclassification does not affect the overall conclusions of the Article. Additionally, “upper CI” has been corrected to “lower CI” throughout the paper to reflect the negative risk difference.